Drug Database
Back to search

Belgium· BE-AMP-SAM662959-00

Ixchiq

A chikungunya, lebend abgeschwächt product containing chikungunya virus, strain delta5nsp3, live, attenuated, registered in Belgium by Valneva Austria. The same ATC class is registered in 5 of our 19 countries.

ATC J07BP01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedIxchiqATCJ07BP01REGISTER NO.BE-AMP-SAM662959-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about chikungunya virus, strain delta5nsp3, live, attenuatedAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Chikungunya, lebend abgeschwächt is registered in 5 of 19 countries.

Countries holding a registration under ATC J07BP01 (chikungunya, lebend abgeschwächt), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 4 of them publish a price we can compare per daily dose
Search chikungunya, lebend abgeschwächt products by name

Chikungunya, lebend abgeschwächt · ATC J07BP01

5 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Norwayprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Chikungunya Virus, Strain delta5nsP3, Live, Attenuated
Manufacturer
Valneva Austria
Country
Belgium (BE)
ATC code
J07BP01
ATC class
Chikungunya, lebend abgeschwächt
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    4886487

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under J07BP01

Chikungunya, lebend abgeschwächt, as other registers publish it.

All chikungunya, lebend abgeschwächt products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4c50270a-3820-4b86-8e58-277dfad9069a
GET /v1/drugs/4c50270a-3820-4b86-8e58-277dfad9069a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder and solvent for solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Ixchiq",
  "name_fr": "Ixchiq",
  "name_nl": "Ixchiq",
  "amp_code": "SAM662959-00",
  "strengths": null,
  "pack_count": 1,
  "substances": [
    "Chikungunya Virus, Strain delta5nsP3, Live, Attenuated",
    "Dipotassium Hydrogen Phosphate",
    "Potassium Dihydrogen Phosphate",
    "Sorbitol",
    "Sucrose"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Chikungunya, Live Attenuated",
  "authorisation_numbers": [
    "EU/1/24/1828/001"
  ]
}
API referenceMCP serverPlans

See everything about chikungunya, lebend abgeschwächt.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console